This syndrome has characteristics of the association of congenital hearing loss and facial dysmorphism (facial asymmetry, a broad nasal root and small nasal alae). It has been described in two members (father and daughter) of one Jewish family. Tempo

https://browser.ihtsdotools.or (...) (...) [HTML] [2018-01-01]

doofheid-craniofaciaal syndroom

https://browser.ihtsdotools.or (...) (...) [HTML] [2018-01-01]

https://browser.ihtsdotools.or (...) [HTML] [2018-01-01]

A rare partial autosomal trisomy/tetrasomy characterized by facial dysmorphism (long thin face, prominent forehead, down-slanting palpebral fissures, prominent nose with broad nasal bridge, prominent chin), pre and postnatal overgrowth, renal anomali

https://browser.ihtsdotools.or (...) (...) [HTML] [2018-01-01]

15q overgroeisyndroom

https://browser.ihtsdotools.or (...) (...) [HTML] [2018-01-01]

https://browser.ihtsdotools.or (...) [HTML] [2018-01-01]

A multiple developmental anomalies syndrome with characteristics of neurological abnormalities (including megalencephaly, hypotonia, intellectual disability, abnormal EEG), dysmorphic facial features (high prominent forehead, grooved nasal tip, ptosi

https://browser.ihtsdotools.or (...) (...) [HTML] [2018-01-01]

syndroom van Freire-Maia-Pinheiro-Opitz

https://browser.ihtsdotools.or (...) (...) [HTML] [2018-01-01]

https://browser.ihtsdotools.or (...) [HTML] [2018-01-01]

Mediastinal tuberculosis | Nasopharyngeal tuberculosis | Tuberculosis of:nose | sinus [any nasal] | NOS (without mention of bacteriological or histological confirmation)

https://icd.who.int/browse10/2 (...) (...) [HTML] [2018-01-01]

https://icd.who.int/browse10/2 (...) (...) [HTML] [2018-01-01]

https://terminologie.nictiz.nl (...) [HTML] [2018-01-01]

Mediastinal tuberculosis | Nasopharyngeal tuberculosis | Tuberculosis of:nose | sinus [any nasal] | confirmed bacteriologically and histologically

https://icd.who.int/browse10/2 (...) (...) [HTML] [2018-01-01]

https://icd.who.int/browse10/2 (...) (...) [HTML] [2018-01-01]

https://terminologie.nictiz.nl (...) [HTML] [2018-01-01]

Floor of nasopharynx Nasopharyngeal (anterior)(posterior) surface of soft palate Posterior margin of nasal:choana | septum

https://icd.who.int/browse10/2 (...) (...) [HTML] [2018-01-01]

https://icd.who.int/browse10/2 (...) (...) [HTML] [2018-01-01]

https://terminologie.nictiz.nl (...) [HTML] [2018-01-01]

IN-CONTEXT TRANSLATIONS

(20) 'nasal tobacco' means a smokeless tobacco product consumed via the nose;

http://www.europarl.europa.eu/ (...) (...) [HTML] [2013-10-07]

(20) „snuiftabak”: een rookloos tabaksproduct dat via de neus wordt geconsumeerd;

http://www.europarl.europa.eu/ (...) (...) [HTML] [2013-10-07]

http://www.europarl.europa.eu/ (...) [HTML] [2013-10-07]

does not fall into any of the following categories: cigarettes, roll-your-own tobacco, pipe tobacco, waterpipe tobacco, cigars, cigarillos, chewing tobacco, nasal tobacco or tobacco for oral use; and

http://www.europarl.europa.eu/ (...) (...) [HTML] [2014-02-25]

niet onder een van de volgende categorieën valt : sigaretten, shagtabak, pijptabak, waterpijptabak, sigaren, cigarillo's, pruimtabak, snuiftabak of tabak voor oraal gebruik; en

http://www.europarl.europa.eu/ (...) (...) [HTML] [2014-02-25]

http://www.europarl.europa.eu/ (...) [HTML] [2014-02-25]

(29) 'smokeless tobacco product' means a tobacco product not involving a combustion process, including chewing tobacco, nasal tobacco and tobacco for oral use;

http://www.europarl.europa.eu/ (...) (...) [HTML] [2013-10-07]

(29) „rookloos tabaksproduct”: een tabaksproduct dat niet via een proces van verbranding wordt geconsumeerd, met inbegrip van pruimtabak, snuiftabak en tabak voor oraal gebruik;

http://www.europarl.europa.eu/ (...) (...) [HTML] [2013-10-07]

http://www.europarl.europa.eu/ (...) [HTML] [2013-10-07]

(23) 'novel tobacco product' means a tobacco product other than a cigarette, roll-your-own tobacco, pipe tobacco, water-pipe tobacco, cigar, cigarillo, chewing tobacco, nasal tobacco or tobacco for oral use placed on the market after entry into force of this Directive;

http://www.europarl.europa.eu/ (...) (...) [HTML] [2013-10-07]

(23) „nieuwsoortig tabaksproduct”: een ander tabaksproduct dan sigaretten, shagtabak, pijptabak, waterpijptabak, sigaren, cigarillo's, pruimtabak, snuiftabak of tabak voor oraal gebruik, dat in de handel wordt gebracht na de inwerkingtreding van deze richtlijn;

http://www.europarl.europa.eu/ (...) (...) [HTML] [2013-10-07]

http://www.europarl.europa.eu/ (...) [HTML] [2013-10-07]

For more results, go to https://pro.wordscope.com to translate your documents with Wordscope Pro!

Chewing and nasal tobacco will be subject to specific labelling and ingredient regulations.

http://europa.eu/rapid/press-r (...) (...) [HTML] [2012-12-18]

Voor pruim- en snuiftabak zullen specifieke regels met betrekking tot etikettering en ingrediënten gelden.

http://europa.eu/rapid/press-r (...) (...) [HTML] [2012-12-18]

http://europa.eu/rapid/press-r (...) [HTML] [2012-12-18]

In Germany, nasal drops cost 1.5–2 times less than the same medicine costs in Lithuania. We take care to ensure that all countries, even the developing ones, have access to medicine.

http://www.europarl.europa.eu/ (...) (...) [HTML] [2008-01-14]

In Duitsland zijn neusdruppels anderhalf tot twee keer goedkoper dan hetzelfde medicament in Litouwen. We zorgen ervoor dat alle landen, zelfs de ontwikkelingslanden, toegang hebben tot medicamenten.

http://www.europarl.europa.eu/ (...) (...) [HTML] [2008-01-14]

http://www.europarl.europa.eu/ (...) [HTML] [2008-01-14]

The activities of the parties overlap in a small number of over-the-counter (OTC) and prescription medicines in the following markets: antihistamines in Germany and the UK; anti-epileptics in Belgium, Ireland, Spain, The Netherlands, Greece, Austria, Germany, Italy, Luxembourg and the UK; coronary therapy drugs in Germany haematinics, iron and all combination drugs used for the treatment/prevention of iron deficiencies in Finland; nasal preparations in Spain; cerebral and peripheral vasotherapeutics for arterial circulation in Germany; stimulants and corticoids for asthma related conditions in Germany.

http://europa.eu/rapid/press-r (...) (...) [HTML] [2006-11-20]

De activiteiten van de partijen overlappen elkaar voor een beperkt aantal receptvrije geneesmiddelen (zogeheten OTC-geneesmiddelen) en receptplichtige geneesmiddelen op de volgende markten: antihistaminica in Duitsland en het Verenigd Koninkrijk, anti-epileptica in België, Ierland, Spanje, Nederland, Griekenland, Oostenrijk, Duitsland, Italië, Luxemburg en het Verenigd Koninkrijk; geneesmiddelen voor de behandeling van hartziekten in Duitsland, bloedvorming bevorderende middelen, ijzer en alle combinatiepreparaten voor de behandeling/preventie van ijzertekorten in Finland; nasale middelen in Spanje; cerebrale en perifere vaatpreparate ...[+++]

http://europa.eu/rapid/press-r (...) (...) [HTML] [2006-11-20]

http://europa.eu/rapid/press-r (...) [HTML] [2006-11-20]

The second project, MUVAPRED, focuses on vaccine delivery by developing HIV and TB vaccines that can be taken orally or as a nasal spray.

http://europa.eu/rapid/press-r (...) (...) [HTML] [2004-03-23]

Het tweede project, MUVAPRED, is toegespitst op de toediening van vaccins: het beoogt de ontwikkeling van HIV- en TB-vaccins die oraal of in de vorm van een neusspray kunnen worden toegediend.

http://europa.eu/rapid/press-r (...) (...) [HTML] [2004-03-23]

http://europa.eu/rapid/press-r (...) [HTML] [2004-03-23]

Using pills or nasal sprays to vaccinate people will also avoid the risks involved in using needles.

http://europa.eu/rapid/press-r (...) (...) [HTML] [2004-03-23]

Het gebruik van pillen of neussprays om patiënten te vaccineren voorkomt ook de risico's die samenhangen met het gebruik van injectienaalden.

http://europa.eu/rapid/press-r (...) (...) [HTML] [2004-03-23]

http://europa.eu/rapid/press-r (...) [HTML] [2004-03-23]

In order to remove the competition concerns, the parties proposed a set of undertakings which effectively remove these concerns: With regard to Erectile Dysfunction, the parties proposed to transfer Pharmacia's two products in development: the dopamine D2 receptor (PNU-142774E) and Apomorphine hydrochloride nasal spray, which is being developed by Pharmacia in cooperation with Nastech Pharmaceutical Company, Inc..

http://europa.eu/rapid/press-r (...) (...) [HTML] [2003-02-26]

Teneinde de concurrentieproblemen uit de weg te ruimen, stelden de partijen een reeks verbintenissen voor: op het gebied van de producten tegen erectiele dysfunctie, stelden de partijen voor om de twee producten van Pharmacia, de dopamine D2-receptor (PNU-142774E) en de apomorfine hydrochloride neusspray, die door Pharmacia worden ontwikkeld in samenwerking met Nastech Pharmaceutical Company, Inc., elders onder te brengen.

http://europa.eu/rapid/press-r (...) (...) [HTML] [2003-02-26]

http://europa.eu/rapid/press-r (...) [HTML] [2003-02-26]

datacenter (1): www.wordscope.nl (v4.0.br)

'Nasal' ->

Date index: 2023-06-09